IP Library Granted Patent US 9,351,819
Granted Patent B2
US 9,351,819 · App. 13/714,606 · Granted May 31, 2016

Device and method for treatment of incision or hernia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,351,819
App. No.
13/714,606
Granted
May 31, 2016
Kind
B2
Abstract

Devices and methods for treating an abdominal incision or hernia are described. An implant for the restoration or prophylactic treatment of an abdominal wall comprises an elongate element and at least one sheet connected to the elongate element along a longitudinal axis of the elongate element. The elongate element is positioned along the line of incision, and the at least one sheet is secured to the abdominal muscles surrounding the incision.

Claims (23)

1. A device for treating an incision, hernia, or abdominal wall defect, comprising:

an elongate element having a cross-section and a longitudinal axis perpendicular to the cross-section, the elongate defining a cylindrical structure that extends along the longitudinal axis;

a first sheet connected to the elongate element extending parallel to the longitudinal axis on a first side of the elongate element; and

a second sheet connected to the elongate element extending parallel to the longitudinal axis on a second side of the elongate element opposite to the first side;

wherein the first and second sheets each comprises a porous biocompatible matrix and the elongate element has a strength that is at least twice a strength of the first sheet and the second sheet;

wherein each of the first sheet and the second sheet extends along a plane parallel to the longitudinal axis to form a first opening between a first portion of the first sheet and a first portion of the second sheet, and a second opening between a second portion of the first sheet and a second portion of the second sheet, the second opening located on an opposite side of the elongate element from the first opening, the first and second openings being sized and dimensioned to receive a portion of the rectus abdominis muscle therebetween such that at least one of the first sheet and the second sheet covers an anterior portion of the rectus abdominis muscle, and the other of the first sheet and the second sheet covers a posterior portion of the rectus abdominis muscle; and

wherein the first sheet and the second sheet each comprises a tissue matrix having the ability to support cellular growth and tissue regeneration.

2. The device of claim 1 , wherein the first sheet and the second sheet each comprises a non-synthetic mesh.

3. The device of claim 1 , wherein the first sheet and the second sheet each comprises an acellular tissue matrix.

4. The device of claim 3 , wherein the first sheet and the second sheet each comprises a dermal matrix.

5. The device of claim 3 , wherein the acellular tissue matrix is derived from tissue that is xenogeneic to a human recipient.

6. The device of claim 5 , wherein the tissue is from an α1,3-galactosyltransferase (α1,3GT) deficient pig.

7. The device of claim 3 , wherein the acellular tissue matrix is derived from tissue that is allogeneic to a human recipient.

8. The device of claim 1 , wherein the elongate element comprises an acellular tissue matrix.

9. The device of claim 8 , wherein the acellular tissue matrix is rolled concentrically into the cylindrical structure.

10. The device of claim 8 , wherein the acellular tissue matrix is thicker than each of the first sheet and the second sheet.

11. The device of claim 1 , wherein the elongate element comprises a piece of connective tissue.

12. The device of claim 11 , wherein the connective tissue is xenogeneic to a human recipient.

13. The device of claim 11 , wherein the connective tissue allogeneic to a human recipient.

14. The device of claim 11 , wherein the connective tissue is a porcine tendon.

15. The device of claim 14 , wherein the connective tissue is from an α1,3-galactosyltransferase (α1,3GT) deficient pig.

16. The device of claim 1 , wherein at least one of the first sheet and the second sheet comprises multiple superimposed sheets.

17. The device of claim 1 , wherein the first sheet and the second sheet are connected to the elongate element using sutures.

Assignments (7)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: HARPER, JOHN R
To: LIFECELL CORPORATION
Reel/Frame 035682/0017 →